CC
Chemours Co
13.70$
+1.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.1% | -42.6% | -36.7% | -64.0% | +226.4% | +7.6% | +78.4% | -43.0% | +24.2% | +1.6% | -8.0% | -26.3% | -213.8% | – | |
| – | -2.2% | -1.9% | -1.5% | +3.9% | +6.4% | -3.9% | +4.0% | +9.5% | +2.9% | -0.9% | -8.2% | +5.5% | -2.0% | +13.0% | |
| – | – | +0.0% | +16.7% | +142.9% | +11.8% | +52.6% | -17.2% | -20.8% | -15.8% | +112.5% | -20.6% | -29.6% | -21.1% | +40.0% | |
| – | – | – | – | – | -569.0% | – | +292.9% | +378.2% | -128.9% | – | – | – | – | – | |
| – | – | – | -190.2% | – | – | -196.3% | – | – | +158.0% | -92.4% | -485.2% | – | -269.7% | – | |
| – | +21.7% | +1.4% | +37.9% | -14.1% | -34.9% | +21.6% | +21.2% | -3.4% | -44.5% | +3.7% | +10.8% | +20.5% | -2.7% | -40.8% | |
| – | +24.3% | -1.2% | +32.1% | -11.3% | – | -203.6% | +31.6% | -0.8% | -51.6% | – | -229.1% | -19.4% | +54.1% | -41.6% | |
| – | – | – | – | +0.0% | -79.0% | +0.0% | +572.7% | +10.8% | +0.0% | +0.0% | -6.1% | -3.2% | -0.7% | -47.3% | |
| – | – | – | – | +2,145.5% | -95.5% | -1,063.6% | +507.5% | -50.0% | – | -1,541.7% | +186.1% | -86.1% | -95.7% | -66.7% | |
| – | – | – | – | +0.0% | -110.9% | – | -142.7% | – | -206.3% | -78.7% | -96.6% | – | -75.8% | -164.2% | |
| – | -16.5% | -61.1% | – | +1,149.1% | -157.6% | – | -381.3% | -57.8% | +7.2% | +24.7% | +22.3% | – | -120.9% | +250.0% | |
| – | – | – | – | +0.0% | +46.4% | +22.0% | -154.3% | – | – | +175.3% | -155.4% | – | -307.6% | – | |
| – | -16.0% | -62.4% | -127.5% | – | – | -10.9% | +181.6% | -73.7% | +219.5% | +0.6% | -17.7% | -58.4% | -633.9% | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.